Welcome to LookChem.com Sign In|Join Free

CAS

  • or

92807-01-7

Post Buying Request

92807-01-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

92807-01-7 Usage

Structure

Heterocyclic compound containing a benzimidazole ring and a thione group

Uses

Commonly used in pharmaceutical research
Precursor or intermediate in the synthesis of various bioactive compounds
Potential pharmacological properties, including antiviral, antimicrobial, and antitumor activities
Derivatives being studied for potential as drug candidates for various diseases
Used in the production of specialty chemicals and in organic synthesis.

Check Digit Verification of cas no

The CAS Registry Mumber 92807-01-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,8,0 and 7 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 92807-01:
(7*9)+(6*2)+(5*8)+(4*0)+(3*7)+(2*0)+(1*1)=137
137 % 10 = 7
So 92807-01-7 is a valid CAS Registry Number.

92807-01-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-hydroxymethyl-2-mercaptobenzoimidazole

1.2 Other means of identification

Product number -
Other names (2-Mercapto-1H-benzoimidazol-5-yl)-methanol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:92807-01-7 SDS

92807-01-7Relevant articles and documents

1-N-AMINOBENZIMIDAZOLE DERIVATIVES

-

Page 22, (2010/02/09)

Provided are 1-N-aminobenzimidazole derivatives represented by the following formula (I): wherein R1 and R2 each represents a substituted or unsubstituted alkyl group or the like, R3, R5 and R6 each represents an alkyl group, alkoxy group, hydrogen atom or the like, R4 represents a substituted or unsubstituted alkyl group or the like, A represents a benzene ring or the like, B represents a hydrogen atom or the like, an n stands for an integer of from 0 to 2, or salts thereof; and medicines containing them. The compounds (I) according to the present invention do not bring about much individual differences in therapeutic effects despite the existence of individual differences in the CYP2C19 activity. At the same dose, they can hence bring about appropriate therapeutic effects for all patients. In addition, they are low in the risk of induction of an interaction or a cancer caused by induction of the CYP1A family. Accordingly, they are useful as peptic ulcer therapeutic agents which are safe and surely bring about therapeutic effects.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 92807-01-7